Induced pluripotent stem cell technology in regenerative medicine and biology.
- Authors
- Pei, Duanqing; Xu, Jianyong; Zhuang, Qiang; Tse, Hung-Fat; Esteban, Miguel A
- Year
- 2010
- Journal
- Advances in biochemical engineering/biotechnology
- PMID
- 20549468
- DOI
- 10.1007/10_2010_72
The potential of human embryonic stem cells (ESCs) for regenerative medicine is unquestionable, but practical and ethical considerations have hampered clinical application and research. In an attempt to overcome these issues, the conversion of somatic cells into pluripotent stem cells similar to ESCs, commonly termed nuclear reprogramming, has been a top objective of contemporary biology. More than 40 years ago, King, Briggs, and Gurdon pioneered somatic cell nuclear reprogramming in frogs, and in 1981 Evans successfully isolated mouse ESCs. In 1997 Wilmut and collaborators produced the first cloned mammal using nuclear transfer, and then Thomson obtained human ESCs from in vitro fertilized blastocysts in 1998. Over the last 2 decades we have also seen remarkable findings regarding how ESC behavior is controlled, the importance of which should not be underestimated. This knowledge allowed the laboratory of Shinya Yamanaka to overcome brilliantly conceptual and technical barriers in 2006 and generate induced pluripotent stem cells (iPSCs) from mouse fibroblasts by overexpressing defined combinations of ESC-enriched transcription factors. Here, we discuss some important implications of human iPSCs for biology and medicine and also point to possible future directions.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | 2019 | 30087005 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Progress in galactomannan-based materials for biomedical application. | Scheibel JM et al. | — | 2025 | → |
| The genetic architecture of the pepper metabolome and the biosynthesis of its signature capsianoside metabolites. | von Steimker J et al. | — | 2024 | → |
| Advanced Manufacturing, Formulation and Microencapsulation of Therapeutic Phages. | Malik DJ et al. | — | 2023 | → |
| Carbon nanosheets to unravel the production of bioactive compounds from microalgae: A robust approach in drug discovery. | Agarwal A et al. | — | 2023 | → |
| Stem cell-based therapy for pulmonary fibrosis. | Cheng W et al. | — | 2022 | → |
| Approaches for manufacture, formulation, targeted delivery and controlled release of phage-based therapeutics. | Malik DJ | — | 2021 | → |
| Characterization of end-of-life mobile phone printed circuit boards for its elemental composition and beneficiation analysis. | Annamalai M et al. | — | 2021 | → |
| Preparation of DNA aptamer and development of lateral flow aptasensor combining recombinase polymerase amplification for detection of erythromycin. | Du Y et al. | — | 2021 | → |
| Protein-protein interactions: Methods, databases, and applications in virus-host study. | Farooq QUA et al. | — | 2021 | → |
| Heart regeneration with human pluripotent stem cells: Prospects and challenges. | Jiang Y et al. | — | 2020 | → |
| Need for Specialized Therapeutic Stem Cells Banks Equipped with Tumor Regression Enzymes and Anti-Tumor Genes. | Ullah M | — | 2020 | → |
| Emergence of Three Dimensional Printed Cardiac Tissue: Opportunities and Challenges in Cardiovascular Diseases. | Charbe NB et al. | — | 2019 | → |
| Engineered Microenvironment for Manufacturing Human Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells. | Lin H et al. | — | 2019 | → |
| Label-free classification of neurons and glia in neural stem cell cultures using a hyperspectral imaging microscopy combined with machine learning. | Ogi H et al. | — | 2019 | → |
| The Role of MicroRNAs in Early Chondrogenesis of Human Induced Pluripotent Stem Cells (hiPSCs). | Stelcer E et al. | — | 2019 | → |
| Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture. | Branco MA et al. | — | 2019 | → |
| Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. | Scarnati MS et al. | — | 2019 | → |
| New approaches targeting brown adipose tissue transplantation as a therapy in obesity. | Soler-Vázquez MC et al. | — | 2018 | → |
| The Dynamic Roles of Mesenchymal Stem Cells in Colon Cancer. | Wang S et al. | — | 2018 | → |
| Comparision of Gingival and Umbilical Cord Stem Cells Based on Its Modulus and Neuronal Differentiation. | Subbarayan R et al. | — | 2017 | → |
| Mesenchymal stem cell-laden hybrid scaffold for regenerating subacute tympanic membrane perforation. | Jang CH et al. | — | 2017 | → |
| Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma. | Bahmad H et al. | — | 2017 | → |
| Quantifying the Metabolome of Pseudomonas taiwanensis VLB120: Evaluation of Hot and Cold Combined Quenching/Extraction Approaches. | Wordofa GG et al. | — | 2017 | → |
| Maintenance of an undifferentiated state of human induced pluripotent stem cells through migration-dependent regulation of the balance between cell-cell and cell-substrate interactions. | Kim MH et al. | — | 2015 | → |
| Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis. | Barczyk M et al. | — | 2015 | → |
| Switching between self-renewal and lineage commitment of human induced pluripotent stem cells via cell-substrate and cell-cell interactions on a dendrimer-immobilized surface. | Kim MH et al. | — | 2014 | → |
| The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine. | Martins AM et al. | — | 2014 | → |
| Urine as a source of stem cells. | Benda C et al. | — | 2013 | → |
| Application of induced pluripotent stem cells in generation of a tissue-engineered tooth-like structure. | Wen Y et al. | — | 2012 | → |
| Cell-based therapies for lung disease. | Garcia O et al. | — | 2012 | → |
| Differentiation of mesenchymal stem cells derived from pancreatic islets and bone marrow into islet-like cell phenotype. | Zanini C et al. | — | 2011 | → |
| Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. | Ho JC et al. | — | 2011 | → |